Objective:

To describe the response to HeberFERON treatment in patients with basal cell neoplasia since the nursing diagnosis.

Methods:

Prospective, longitudinal and descriptive study carried out in the ophthalmology service of Abel Santamaría Cuadrado General Teaching Hospital of Pinar del Río, in the period from July to December 2017. The study population consisted of 12 patients with basal cell neoplasia and treated with HeberFERON. The variables analyzed were age, sex, skin phototype, location and size of the lesion, response to treatment, and nursing diagnosis.

Results:

50.00% of the patients studied belonged to the age group of 71 years or older, of male sex, and whose lesion was less than 20 mm in size. 66.66% had a skin phototype II. The lesion was located in the lower eyelid and had a complete response to treatment with HeberFERON. Based on the nursing diagnosis, lack of confidence and knowledge about the disease was in 100% of the cases; fear of death, in 91.66%; deterioration of skin and tissues around, in 83.33%.

Conclusions:

The majority of the patients treated with HeberFERON presented a complete response to the therapy, resulting in a total disappearance of the neoplasm.

        · resumen en Español     · texto en Español     · Español ( pdf )